Showing posts with label Medical Devices. Show all posts
Showing posts with label Medical Devices. Show all posts

14 Jan 2015

Global Pain Management Devices Market to Grow at a CAGR of 13.1% Between 2012 and 2018



According to a new research study on the global pain management devices market published by Transparency Market Research, states that the market will observe growth from US$2.0 billion in 2011 to US$5.0 billion by 2018, registering a CAGR of nearly 13.1% over the period. The report is titled “Pain Management Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018”. 

The report states that technological advancements observed in new products in the market and rising sophistication of the products have helped revolutionize the global pain management devices market. The overall field of pain management has significantly benefitted from the huge volume of past as well as ongoing research activities undertaken in the area of pain sensations and processes related with their neurotransmission.

Browse the full Global Pain Management Devices Market (Electrical Stimulators, Radiofrequency Ablation, Analgesic Pumps, Neurostimulation Devices) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018 report at http://www.transparencymarketresearch.com/pain-management-drugs-devices.html

A rising geriatric population base across the globe, which has consequently led to increased prevalence of age-related health conditions such as arthritis and chronic conditions such as cancer and diabetes, is also driving the global pain management devices market. The prolonged use of pain management drugs induces many serious side-effects on patient’s health, owing to which better ways for managing pain are always aspired by the end-user. This trend has always benefitted the market for pain management devices. 

The report segments the global pain management devices market into three major parts: the variety of product types available in the market, chief application areas of pain management devices, and chief regional markets.

The product type electrical stimulators, and especially of the variety Transcutaneous Electrical Nerve Stimulators (TENS) is currently the most widely used pain management devices types in the market. The market value of this product segment was nearly US$208.7 million in 2011, and is expected to grow at a CAGR of 8.2% during the report’s forecast period. However, the market segments radiofrequency ablation and neurostimulation devices are expected to grow at the highest rates during the forecast period, owing to rising prevalence of a variety of neuropathic diseases across the globe. The market segment neurostimulation devices is expected to grow at a CAGR of nearly 15.2% over the forecast period. 

On the geographic front, the regional market of North America reserved the largest share of the global pain management devices market in 2011. However, the regional market of Asia is predicted to grow at the highest pace, nearly 21.7%, over the period of report’s forecast. The growth can be attributed to an overall rise in awareness about early diagnosis and ongoing management of chronic pain conditions and rising disposable incomes in the region, making high-end pain management devices feasible to the population.


Also, WHO has predicted that Asia will have the world’s largest number of diabetic patients by the end of the year 2020. This, coupled with favorable medical reimbursement policies in the region will drive future demands for pain management devices.

The predominantly oligopolistic nature of the global pain management devices market features only a few chief businesses such as Kimberly Clark, St. Jude Medical, Medtronic Inc, and Boston Scientific.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. 

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports. 

Contact

Mr.Nachiket
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

10 Jul 2014

Pulmonary Drug Delivery Systems Market A Brief Insight 2013 - 2019

The global Pulmonary Drug Delivery Systems Market was valued at USD 21.03billion in 2012 and is expected to grow at a CAGR of4.5% from 2013 to 2019, to reach an estimated value of USD 28.70billion in 2019.

Browse Global Pulmonary Drug Delivery Systems Market Report with Full TOC at http://www.transparencymarketresearch.com/pulmonary-drug-delivery-systems.html

Pulmonary drug delivery systems use the respiratory tract to deliver medications to treat diseases such as asthma, chronic obstructive pulmonary disease (COPD) and cystic fibrosis. The history of use of these systems dates back to over 60 years ago, when these systems were initially indicated for treating only respiratory diseases - asthma and COPD. Continued development in this area facilitated their application in the treatment of other diseases as well, including cystic fibrosis and diabetes. Exubera was the first inhalable insulin launched by Pfizer Ltd. and Nektar Pharma for treating diabetes, in 2006. However,owing to its poor sales performance, Exubera was withdrawn from the market within a yearof its launch which led other partnerships such as Alkermes/Eli Lilly and Aradigm/Novo Nordisk to abandon the development process of inhalable insulin therapies. Currently,Afrezza by MannKind Corporation is the only inhalable insulin under review by the U.S. FDA and is likely to be approved for marketing in the U.S. by mid-2014.

The global market for pulmonary drug delivery systems includes metered dose inhalers (MDIs), dry powder inhalers (DPIs) and nebulizers. Initially, MDIs used chlorofluorocarbons (CFCs) as propellants.Later due to rising environmental concerns and pressure from Montreal Protocol (1987) recommendation to phase out CFCs, manufacturers started using hydrofluoroalkanes (HFAs) that are considered as safe propellants causing negligible threat ofozone depletion.MDIs accounted for the largest share (56.8%) of the total global pulmonary drug delivery systems market in 2012 anPulmonary Drug Delivery Systems Marketd this segment is expected to grow at a CAGR relatively lower than that for DPIs and nebulizer market segments. This is primarily because of the environmental concerns related with the use of CFCs, which led to ban on CFC-based inhalers. Although manufacturers have now started using HFAs the fact that HFAs also emit gases causing ozone layer depletion has led manufacturers to shift their focus more towards the development of DPIs. During the forecast period 2013 to 2019, DPIs are expected to witness greater demand than MDIs owing to propellant free nature of these systems. The market for nebulizers has been anticipated as the fastest growing segment of the pulmonary drug delivery systems market mainly due to the technical advances leading to portability of these devices and rising demand for home based care. The global pulmonary drug delivery systems market has also been segmented on the basis of their application in treating various diseases such as asthma, COPD and cystic fibrosis.

Among the four major geographies of the world, North America and Europe accounted for the first and second largest market shares in 2012 of the global pulmonary drug delivery systems market.The market in these regions is characterized by a range of factors such as patent expiry of many blockbuster inhaler brands, increasing prevalence of asthma and COPD, focus on reducing treatment costs, growing environmental concerns and aging population.Asia-Pacific held the third largest share of the global pulmonary drug delivery systems market in 2012. The region being home to more than half of the world's population represents a large pool of patients suffering from respiratory diseases such as asthma and COPD, and thus, represents a high growth potential market for pulmonary drug delivery systems, estimated to grow at a CAGR of 6.6% during the forecast period.Emerging economies of India and China are expected to favor the positive growth of pulmonary drug delivery systems market in the region by contributing to the rise in healthcare expenditure.

The global market for pulmonary drug delivery systems is dominated by companies such as GlaxoSmithKline, plc, Boehringer Ingelheim, AstraZeneca, Merck & Co., Philips Respironics and Omron Healthcare. These players collectively accounted for more than 75% of the global pulmonary drug delivery systems market revenue in 2012.Some other players operating in this market include Novartis AG, CareFusion Corporation, 3M Health Care, PARI Respiratory Equipment, Inc., Sunovion Pharmaceuticals Inc., Allied Healthcare Products, Inc., and GF Health Products Inc.
The global pulmonary drug delivery systems market is segmented as follows:

Pulmonary Drug Delivery Systems Market, by Product Type
  • Metered Dose Inhalers (MDIs)
  • Dry Powder Inhalers (DPIs)
  • Nebulizers
Pulmonary Drug Delivery Systems Market, by Application
  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Cystic Fibrosis
Pulmonary Drug Delivery Systems Market, by Geography
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)
Browse all Medical Devices Market Research Reports @ http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

Contact
Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

30 Jun 2014

Clinical Laboratory Services Market Analysis 2013 - 2019

Clinical Laboratory Services Market  

The global clinical laboratory services market was valued at USD 162.71 billion in 2012 and is expected to grow at a CAGR of 5.8% from 2013 to 2019, to reach an estimated value of USD 241.37 billion in 2019.   


Clinical laboratories refer to the centers for conducting diagnostic testing and related services to identify disease causes, level of progression (stage) of the disease, resultant abnormalities and imbalances in the physiology, and other such factors. Along with processing samples and generating patient reports, players in this market also offer informatics solutions which help in effective data management for the large volume of tests ordered and performed each day. The global market for clinical laboratory services is expected to grow at a CAGR of 5.8% during the forecast period due to the increasing incidence rates of diseases worldwide along with the introduction of newer and sophisticated diagnostic tests.  

The market for clinical laboratory services has been segmented by different categories of tests performed such as clinical chemistry, genetic tests, medical microbiology & cytology tests and other esoteric tests. The market for medical microbiology & cytology tests is expected to grow at the highest CAGR of 7.1% during the forecast period due to the increasing burden of infectious diseases globally, that demands large testing volume capacities from clinical laboratories. Although core laboratory tests, which constitute the clinical chemistry market segment, are basic tests extensively conducted across patient populations, this market segment is expected to witness mediocre growth at a CAGR of 5.3%. This is due to the limited scope for innovation in this market in terms of developing newer tests and the growing importance of informatics solutions in the same.  

On the basis of geographic regions, this market was studied with reference to North America, Europe, Asia-Pacific and Rest of the World. North America and Asia-Pacific regions are expected to emerge as highly attractive markets for clinical laboratory services in the future, in terms of market revenue and growth respectively. The market is divided into three major types of service providers- clinic-based, hospital-based and stand-alone laboratories. Of these, hospital-based laboratories generate the maximum revenue globally are expected to continue to do so during the forecast period.   


The market for clinical laboratory services is fragmented, with Quest Diagnostics, Inc. (U.S.) and Laboratory Corporation of America Holdings (U.S.) dominating the market in terms of revenue generation. Some of the other key players include Sonic Healthcare (Australia), Genoptix Medical Laboratory (U.S.), Labco S.A. (France), Healthscope Ltd. (Australia), Bio-Reference Laboratories (U.S.), and Bioscientia Healthcare (Germany).   

Clinical Laboratory Services Market, by Test Type   
  • Clinical Chemistry 
  • Medical Microbiology & Cytology 
  • Human & Tumor Genetics 
  • Other Esoteric Tests    

Clinical Laboratory Services Market, by Service Provider   
  • Clinic-based 
  • Hospital-based 
  • Stand-alone    

Clinical Laboratory Services Market, by Geography   
  • North America 
  • Europe 
  • Asia-Pacific 
  • Rest of the World (RoW)    

Browse all Medical Devices Market Research Reports @ http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html   

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. 
  
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.   

Contact 

Ms. Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/





27 Jun 2014

3D Printing in Medical Applications Market - A Current Market Overview and Future Prospects 2013 - 2019

3D Printing in Medical Applications Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

The global 3D Printing in Medical Application Market was valued at USD 354.5 million and is expected to grow at a CAGR of 15.4% from 2013 to 2019 to reach a market of USD 965.5 million by 2019.


3D Printing in Medical Applications Market
Increasing demand in the medical industry for various technological developments has augmented the growth of 3D printing in numerous medical applications. 3D printing has provided the medical industry with a plethora of solutions for large problems. It has revolutionized the healthcare segment by providing surgical guides, medical implants, surgical instruments and bioengineered products. 3D printing in medical applications is expected to grow at a significant CAGR of 15.4% from 2013 to 2019. This growth is attributed to an increase in demand of quick and cheap solutions for medical problems. In addition, the market would also grow owing to an increase in investment in R&D for the technologies of 3D printing. The growth of this market may, however, get affected due to lack of trained professionals and raw materials.

3D printing technologies help in manufacturing medical implants and surgical guides such as dental, orthopedic and cranio-maxillofacial. In addition, they increase the efficiency of surgical instruments by manufacturing self-sterilizing surgical instruments. The manufacturing of these bio-models is done by using various raw materials such as metal, polymer, ceramic and biological cells. These raw materials, when used with 3D printing technologies such as laser beam melting (LBM), electron beam melting (EBM), droplet deposition manufacturing (DDM) and photopolymerization, result in the manufacturing of various bio-models.

Geographically, although the North American region constituted the largest market for 3D printing in medical applications in year 2012;Europe is expected to witness the highest growth rate of more than 15% from 2013 to 2019. This growth is mainly due to the increase in government funding in this market along with various small and big mergers and acquisitions of companies for technological advancement coupled with enhancement in application areas. Favorable reimbursement policies in the region will also provide the required impetus for the growth of the market.
 3D Printing in Medical Applications Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

The 3D printing in medical applications market is predominantly an oligopolistic one and is ruled by players such as EnvisionTEC GmbH, 3D System, Stratasys Inc., Materialise NV and others.
The global 3D printing in medical applications market has been segmented as below:

3D printing in Medical Applications Market, by Applications

  • Surgical Guides
    • Orthopedic
    • Dental
    • Cranio-maxillofacial
  • Implants
    • Orthopedic
    • Dental
    • Cranio-maxillofacial
  • Surgical Instruments
  • Bioengineering
3D printing in Medical Applications Market, by Technologies

    • Electron Beam Melting (EBM)
    • Laser Beam Melting (LBM)
    • Photopolymerization
    • Stereolithograp 
    • Two Photon Polymerization
    • Digital Light Processing
    • Droplet Deposition Manufacturing
    • Inkjet Printing
    • Fused Deposition Modeling
    • Multiphase Jet Solidification
3D Printing in Medical Applications Market, by Raw Materials

    • Metals
    • Polymers
    • Ceramics
    • Biological Cells
3D printing in Medical Applications Market, by Geography

    • North America
    • Europe
    • Asia Pacific
    • Rest of the World (RoW)
Browse all Medical Devices Market Research Reports @ http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: +1-866-552-3453
Email: 
sales@transparencymarketresearch.com
Visit: 
http://www.transparencymarketresearch.com/

26 Jun 2014

Minimally Invasive Surgery Market - An Overview of Growth Factors 2013 - 2019

Minimally Invasive Surgery Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
The global Minimally Invasive Surgery Market was valued at USD 25.03 billion and is expected to grow at a CAGR of 10.5% during the forecast period 2013 to 2019 to reach a market value of USD 50.60 billion by 2019.


Minimally invasive surgeries (MIS) are performed with minimal incision in the patient's body and ensure the patients with a reduced duration of hospital stay, minimal patient trauma and reduced recovery time. These advantages associated with MIS along with the rising awareness regarding the same, have increased its popularity among patients as well as physicians.The global market for minimally invasive surgeryhas been estimated togrowat the rate of 10.5% during the forecast period 2013 to 2019. This growth is attributed mainly to the increasing incidences of various diseases such as arthritis, cancer and cardiovascular diseases that usually require surgical treatment of the condition. Aging of the global population, especially in the developed countries, will also trigger the growth of this market since elderly people carry a high risk in terms of success of the surgery and MIS would ensure minimal trauma to the already compromised health of the patient. Likewise, introduction of technologically advanced products in the market such as confocal micro endoscopes, narrow band imaging endoscopes and HD cameras for endoscopes, will further propel the growth of this market since these technologies provide better visualization during the surgery.

Minimally invasive surgeries involve three major categories of devices that include surgical devices, monitoring & visualization devices, and endoscopy devices.The market for surgical devices (ablation devices, electrosurgical devices, and medical robotic systems) accounted for the largest share by revenue of the overall MIS market in 2012. This segment is also expected to show the highest growth during the forecast period, at a CAGR of 11.8%. This growth is attributed to their extensive utilization in performing various minimally invasive procedures with maximum accuracy and ease of operation for the physician.

The different types of surgeries that can be performed via minimally invasive technologies include orthopedic, breast, vascular, thoracic, gynecological, bariatric, cardiac, gastrointestinal and urological surgery. Among these, in 2012, the cardiac surgery market accounted for the largest share in terms of revenue due to the large patient population suffering from cardiovascular diseases (CVDs) globally and the ever-increasing incidence rates of CVDs. However, the market for cosmetic surgery will grow at the highest CAGR of 14% during the forecast period 2013 to 2019. This is due to the change in lifestyle of the population along with high adoption rates for these procedures in developed as well as developing markets.

The North American region accounted for the largest share by revenue of the global minimally invasive surgery market in the year 2012, owing to the large number of elderly people, a well-established reimbursement scenario and presence of leading device manufacturers in the region. However, Asia-Pacific is expected to show the highest growth rate of 13.3% from 2013 to 2019. This is attributed to the rise in disposable income due to economic development in key markets such as India and China, and high adoption rates in the developed market of Japan. Similarly, in the constantly increasing patient pool, aging population and rising healthcare expenditures will also augment the growth of the market. The European and RoW markets are expected to show the slowest growth during the forecast period, although the European market is expected to maintain its position with the second largest revenue share in 2019.
 Minimally Invasive Surgery Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
The global minimally invasive surgery market is dominated by players such asIntuitive Surgical, Inc., GE Healthcare, Siemens Healthcare, Philips Healthcare, Medtronic, Inc., Stryker Corporation and Biomet, Inc.These companies together accounted for the largest share in terms of revenue in 2012, at over 45%. Some other key players in the market include Abbott Laboratories, DePuy Synthes, Inc., ArthroCare Corporation, Given Imaging Ltd., NuVasive, Inc., Teleflex, Inc. and Varian Medical Systems, Inc.

The global minimally invasive surgery market has been segmented as below:

Minimally Invasive Surgery Market, by Product Type

  • Surgical Devices
    • Ablation Devices
      • Radiofrequency Ablation
      • Microwave Ablation
      • Cryoablation
      • Others
    • Electrosurgical Devices
    • Medical Robotic Systems
  • Monitoring & Visualization Devices
    • X-Ray Devices
    • Computed Tomography (CT) Scanners
    • Magnetic Resonance Imaging (MRI) Equipment
    • UltrasoundEquipment
    • Others
  • Endoscopy Devices
Minimally Invasive Surgery Market, by Type of Surgery

  • Orthopedic Surgery
    • Spinal Surgery
    • Joint Replacement Surgery
  • Cosmetic Surgery
  • Breast Surgery
  • Vascular Surgery
  • Thoracic Surgery
  • Gynecological Surgery
  • Bariatric Surgery
  • Cardiac Surgery
  • Gastrointestinal Surgery
  • Urological Surgery
Minimally Invasive Surgery Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)
Browse all Medical Devices Market Research Reports @ http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Web: http://www.transparencymarketresearch.com/


25 Jun 2014

Surgical Equipment Market Forecast 2013 - 2019

Surgical Equipment Market
The global Surgical Equipment Market was valued at USD 8.43 billion in 2012 and is expected to grow at a CAGR of 4.2% from 2013 to 2019, to reach an estimated value of USD 11.28 billion in 2019.

Browse Global Surgical Equipment Market Report with Full TOC at http://www.transparencymarketresearch.com/surgical-equipment-market.html

Surgical equipment such as sutures, staples, scalpels, forceps, retractors, scissors, and electrosurgical devices are used for a number of functions during surgical procedures. For instance, sutures and staples are used to close the wound after an injury; scalpels are highly sharp edged cutting instruments used for making incisions, and forceps are used for holding, clamping, dilating and suctioning during surgical procedures. In this report, the global market for surgical equipment has been segmented into three major product types, namely, surgical sutures and staples, surgical handheld instruments and electrosurgical devices. Of these, surgical sutures and staples market has been further segmented into surgical sutures and surgical staples individually, while the market for surgical handheld instruments has been segmented into scalpels, forceps, retractors and scissors.

In 2012, the surgical sutures and staples segment accounted for the largest share (55.6%) of the total surgical equipment market revenue. However, during the forecast period 2013 to 2019,owing to slow growth rate, it is likely to lose some of its share. On the other hand, the electrosurgical devices market segment is expected to show highest growth at a CAGR of 6.1%,owing to the growing demand for minimally invasive procedures that extensively utilize these devices.Covidien plc, ERBE Elektromedizin GmbH and CONMED Corporation are the major players in the electrosurgical devices market with a combined market share of around 60% in 2012.The market for surgical sutures and staples is dominated by players such as Ethicon, Inc., B. Braun Melsungen AG and Covidien plc. In the surgical handheld instruments market, B. Braun Melsungen AG, Integra LifeSciences Holdings Corporation, Covidien plc, Aspen Surgical Products, Inc., and KLS Martin LP are prominent players with significant market shares.

During the forecast period 2013 to 2019, the market for surgical equipment will be majorly driven by factors such as year on year increase in the number of surgical procedures, rise in demand for minimally invasive procedures, worldwide aging population and technological developments leading to innovative products. Due to the fact that electrosurgical devices play key role during minimally invasive procedures, rise in the demand for these procedures will in turn trigger the demand for electrosurgical devices. On the other hand, factors such as rising demand for advanced wound closure materials such as glues and fibrin sealants, implementation of Patient Protection and Affordable Care Act (PPACA) in the U.S., side effects associated with products leading to product recalls, and intense price competition from local manufacturers may pose significant challenges before players operating in the surgical equipment market.

Geographically, North America and Europe were the first and second largest regional markets for surgical equipment, followed by Asia-Pacific and Rest of the World (RoW), respectively. In North America and Europe, market growth will be primarily driven by technical advances leading to product innovation. On the other hand, in Asia-Pacific and RoW markets, factors such as the presence of a large pool of patients likely to undergo various surgical procedures, rising healthcare expenditures and increasing awareness regarding advanced surgical equipment are expected to play key role in driving market growth.

Ethicon, Inc., Covidien plc, B. Braun Melsungen AG, ERBE Elektromedizin GmbH, CONMED Corporation, KLS Martin LP, Integra LifeSciences Holdings Corporation, Medicon eG, Stryker Corporation, Aspen Surgical Products, Inc. and CareFusion Corporation are the major players competing with each other in the surgical equipment market. These players face significant threats from local players especially in Asia-Pacific region as they offer various types of surgical equipment at very low prices that leads to intense price competition.
The global surgical equipment market is segmented as follows:

Surgical Equipment Market, by Product Type

  • Surgical Sutures and Staples
    • Surgical Sutures
    • Surgical Staples
  • Surgical Handheld Instruments
    • Scalpels
    • Forceps
    • Retractors
    • Scissors
  • Electrosurgical Devices
Surgical Equipment Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)
Browse all Medical Devices Market Research Reports @ http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

 

Copyright @ 2015 Market Trends Reports.